SCHEMBL1462230

SCHEMBL1462230

CC(Cc1ccc(F)c(N)c1F)CS(N)(=O)=O

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8215818 0.71 CA2 (0.39) CA2
SCHEMBL671337 0.66 LOXL2 (0.39)
SCHEMBL29467988 0.66 LOXL2 (0.39)
SCHEMBL11688566 0.64 CA1 (0.43) CA2
SCHEMBL30007084 0.64 CYP3A4 (0.38) CA2
SCHEMBL1492048 0.62 CYP2C9 (0.48)
SCHEMBL10129554 0.62 ACLY (0.44) CA2
SCHEMBL16058359 0.61 CA2 (0.45) CA2
SCHEMBL455108 0.61 SLC6A2 (0.41)
SCHEMBL28820319 0.61 RAB9A (0.48) CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2493865-A2 RAF INHIBITOR COMPOUNDS AND METHODS OF USE THEREOF Array Biopharma, Inc. (US) 2012-09-05 EP disclosed
WO-2011025938-A2 RAF INHIBITOR COMPOUNDS AND METHODS OF USE THEREOF ARRAY BIOPHARMA INC. (US) 2011-03-03 WO disclosed